Veli Bakalov, MD
@HemeOncBuddy
Followers
1K
Following
4K
Media
198
Statuses
1K
Thoracic Oncologist at MD Anderson Cancer center at @CooperHealthNJ, Author of #HemeOncBuddy app, happy husband and dad 🤗
Joined December 2017
🎉🎊🎉Finally out!🔥🔥🔥 HemeOncBuddy app on most important clinical trials in hematology and oncology! Please spread the word! 🗣📢 https://t.co/jDSGMXomwO *only ~100 trials for now. Hope I can double the number of trials in next couple months. #ASH #ASCO #medtwitter
21
30
115
🚨🔥@OncoAlert Hot off the press. @US_FDA just approved: ⭐️#Sevabertinib ✅ For patients with advanced #HER2 mutant Non-Small Cell #LungCancer who received prior systemic therapy. Approval is based on Results of #SOHO-01 Phase 1/2 Trial. 👇🏻 https://t.co/JY9QLs7X8Z
🔥🚨 Hot Off The Press Just published @NEJM In conjunction with presentation @myESMO #ESMO25 Results of #SOHO-02 Phase 1/2 Trial of: ⭐️#Sevabertinib in advanced #HER2 mutant Non-Small Cell #LungCancer. #ORR: ✅71% in treatment naive ✅64% in pre-treated (No prior HER2 Tx)
5
14
53
I was diagnosed with stage 4 EGFR+ #lungcancer about 3 yrs ago, & actually I’ve learned to live with it & make the best of every single day. I live a really good life - yoga helps me massively, & so does looking after my dogs, getting out in the fresh air, & the sun on my face.
1
5
22
My favorite podcast! Never miss the episode! 👍🏼👏
0
0
0
Come join Nevada's first BMT/cell therapy! We are already super successful. We need another doc. I can only last so long doing Q2week call! We are helping patients in great need. I have never asked for a retweet, but colleagues please retweet. https://t.co/H9Xu1MdwSa
8
61
124
sTARLATAMAB has a bright future! Thank you @BalazsHalmosMD
We just learned for a fact that tarlatamab is indeed STARlatamab at the center of the small cell lung cancer Universe! @HemeOncBuddy #lcsm
0
0
3
He is back! @Papa_Heme 🎉🥳👏🎊
Ophthalmologists are rejoicing everywhere! Business will be booming. Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma | GSK
0
0
0
🚨🔥@OncoAlert Hot Off The Press Just published @NEJM
#OverallSurvival data from: ⭐️#FLAURA2 trial of #Osimertinib + #Chemotherapy vs #Osimertinib in 1st line Tx for patients with #EGFR+ advanced #LungCancer (#NSCLC). ✅Impressive Statistically Significant & Clinically
2
27
66
🔥🚨 Hot Off The Press Just published @NEJM In conjunction with presentation @myESMO #ESMO25 Results of #SOHO-02 Phase 1/2 Trial of: ⭐️#Sevabertinib in advanced #HER2 mutant Non-Small Cell #LungCancer. #ORR: ✅71% in treatment naive ✅64% in pre-treated (No prior HER2 Tx)
3
15
55
Proud of our team's paper on reflex protocol combining NGS + PD-L1 IHC in stage IB+ NSCLC showing ⬇️ turnaround time by ~7 days, streamlines workflow, and demonstrates feasibility in a clinical pathology lab. Key findings: • Reflex testing ➡️ faster NGS and ⬇️ delays •
academic.oup.com
AbstractObjective. Targeted therapy in non–small cell lung cancer (NSCLC) is now often included as first-line treatment in the neoadjuvant and adjuvant set
1
0
4
Next level cancer care with Dr Navid Radjal!
Dr. Navid Redjal, a brain surgeon at MD Anderson Cancer Center at Cooper, explains awake craniotomy—a special type of #brainsurgery used to treat complex brain tumors including primary and metastatic #braincancer. 🧠
1
0
2
Dr. Navid Redjal, a brain surgeon at MD Anderson Cancer Center at Cooper, explains awake craniotomy—a special type of #brainsurgery used to treat complex brain tumors including primary and metastatic #braincancer. 🧠
0
1
2
The 2025 LBCL Guidelines are out ! Fantastic work made by the @EHA_Hematology Cc @c_thieblemont
https://t.co/OR8RZ95Wt3
32
71
168
Anticoagulant Conversion Handy Sheet Kudos to our friends at @gloshospitals Good for Everyday Liaison Inquiries #medicine #medtwitter #MedEd #blooducation #Hematology
4
69
284
Does survival still matter in oncology? In this “tribute” episode, we joined w/@vkprasadlab members: definitions, examples, solutions.. all you want to know about post-protocol care and how it can distort overall survival results! We missed you, Vinay, my friend @VPrasadMDMPH!
8
18
48
New standard of care!
🔥🚨@OncoAlert HOT OFF THE PRESS. Just presented at the presidential symposium @IASLC #WCLC25 The long awaited #OverallSurvival data from: ⭐️#FLAURA2 trial of #Osimertinib + #Chemotherapy vs #Osimertinib in 1st line Tx for patients with #EGFR+ advanced #LungCancer (#NSCLC).
0
1
4
Check out our new publication in Annals of Medicine! A national survey of >400 IM residents on research perceptions during training. Huge thanks to my co-authors, the residents who participated, and Dr. Kapetanos for his invaluable mentorship! @AHNIMres @UmnCardsfellow @UMN_DCVM
How do internal medicine residents feel about research? Lead by @LAlhuneafat, we surveyed >400 IM residents across the U.S. to find out. Here's what we learned.👇 🔗 https://t.co/MW3g9WjaSo
#MedEd #MedTwitter #IMResearch
2
6
35
High quality 🤌
Whatsapp group names for medical specialties: Dentistry - Tooth be told Cardiology - Pump it up Oncology - Chemo sapiens Pathology - Dead serious Ortho - Joint venture Pediatrics - Dream big Ob/Gyn - Ovary achievers Dermatology - It's just a rash Ophthalmology - 20/20 and beyond
0
1
4